Expert Advice
Tips, insights, and expert advice to help you manage brain and eye disease.
Our tools will help you understand and manage symptoms, treatment, and prevention of these diseases.
An ophthalmologist explains the differences between dry and wet age-related macular degeneration.
People suffering from age-related macular degeneration (AMD) can lose some or all of their central vision. The disease rarely affects the side (peripheral) vision, and for those whose central vision is affected, in some circumstances vision may be regained.
A dozen years ago, there were hardly any treatments for age-related macular degeneration (AMD). Fortunately, there are now several, and the best way to evaluate their effectiveness is to review the results of large, well-designed clinical trials.
Drusen are small protein and lipid deposits under the retina of the eye. They are the defining feature of age-related macular degeneration. Learn about diagnosis and risks.
Learn what to expect from a macular degeneration eye examination including diagnostic tests, risk assessment, and treatment evaluations.
Does age-related macular degeneration lead to blindness? Learn how the disease is diagnosed, what to expect next, and how following your doctor's instructions can help you retain your vision.
Cutting-edge research is exploring the potential for stem cell treatments for macular degeneration. Learn about recent progress and cell therapy clinical trials.
Learn about genes that are closely associated with age-related macular degeneration, and whether genetic testing is currently recommended.
The diagnosis of age-related macular degeneration (AMD) raises a number of concerns. Here’s a list of the top five questions my patients ask me.
Learn why the distinction between hard and soft drusen is important, and how the type of drusen that you have may influence your risk of vision loss.
